Medical alternatives to oocyte donation in women with premature ovarian failure: a systematic review

References

• Alper MM, Jolly EE, Garner PR. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol 1986;67: 59S–62S
   Web of Science ®Google Scholar
• Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604–6
   PubMed Web of Science ®Google Scholar
• Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:804–10
   PubMed Web of Science ®Google Scholar
• Coulam CB. The prevalence of autoimmune disorders among patients with primary ovarian failure. Am J Reprod Immunol 1983;4:63–6
   Web of Science ®Google Scholar
• Alper MM, Garner PR. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol 1985;66:27–30
   PubMed Web of Science ®Google Scholar
• Anasti JN. Premature ovarian failure: an update. Fertil Steril 1998;70:1–15
   PubMed Web of Science ®Google Scholar
• Santoro N. Mechanism of premature ovarian failure. Ann Endocrinol (Paris) 2003;64:87–92
   PubMed Web of Science ®Google Scholar
• van Kasteren YM, Hoek A, Schoemaker J. Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertil Steril 1995;64:273–8
   PubMed Web of Science ®Google Scholar
• Taylor AE, Adams JM, Mulder JE, et al. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab 1996;81:3615–21
   PubMed Web of Science ®Google Scholar
• van Kasteren YM, Braat DD, Hemrika DJ, et al. Corticosteroids do not influence ovarian responsiveness to gonadotropins in patients with premature ovarian failure: a randomized, placebo- controlled trial. Fertil Steril 1999;71:90–5
   PubMed Web of Science ®Google Scholar
• Tartagni M, Cicinelli E, De Pergola G, et al. Effects of pretreatment with estrogen on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril 2007;87:858–61
   PubMed Web of Science ®Google Scholar
• Badawy A, Goda H, Ragab A. Induction of ovulation in idiopathic premature ovarian failure: a randomized double-blind trial. Reprod Biomed Online 2007;15:215–9
   PubMed Web of Science ®Google Scholar
• Nelson LM, Kimzey LM, White BJ, Merriam GR. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril 1992;57:50–5
   PubMed Web of Science ®Google Scholar
• Check JH, Nowroozi K, Chase JS, et al. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:811–5
   PubMed Web of Science ®Google Scholar
• Buckler HM, Healy DL, Burger HG. Does gonadotropin suppression result in follicular development in premature ovarian failure? Gynecol Endocrinol 1993;7:123–8
   PubMed Web of Science ®Google Scholar
• Corenblum B, Rowe T, Taylor PJ. High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 1993;59:988–91
   PubMed Web of Science ®Google Scholar
• Anasti JN, Kimzey LM, Defensor RA, et al. A controlled study of danazol for the treatment of kariyotypically normal spontaneous premature ovarian failure. Fertil Steril 1994;62:726–30
   PubMed Web of Science ®Google Scholar
• Surrey ES, Cedars MI. The effect of gonadotropin suppression on the induction of ovulation in premature ovarian failure patients. Fertil Steril 1989;52:36–41
   PubMed Web of Science ®Google Scholar
• Rosen GF, Stone SC, Yee B. Ovulation induction in women with premature ovarian failure: a prospective, crossover study. Fertil Steril 1992;57:488–9
   Web of Science ®Google Scholar
• Louvet JP, Vaitkuaitis JL: Induction of follicle-stimulating hormone (FSH) receptors in rat ovaries by estrogen priming. Endocrinology 1976;799:758-64
   Google Scholar
• Richards JS, Ireland JJ. Hormone receptor regulation by estradiol follicle-stimulating hormone and luteinizing hormone. Endocrinology 1976;99:1562–70
   PubMed Web of Science ®Google Scholar
• Check JH, Chase JS, Spence M. Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy. Am J Obstet Gynecol 1989;160:114–5
   PubMed Web of Science ®Google Scholar
• Wolfe CDA, Stirling RW. Premature menopause associated with autoimmune oophoritis. Br J Obstet Gynecol 1988;95:630–2
   PubMedGoogle Scholar
• Rabinowe SL, Ravnikar VA, Dib SA, et al. Premature menopause: monoclonal antibody defined T lymphocyte abnormalities and antiovarian antibodies. Fertil and Steril 1989;51:450–4
   PubMed Web of Science ®Google Scholar
• Hoek A, van kasteren Y de Haan-Meulman M, et al. Analysis of peripheral blood lymphocytes subsets, NK cells and delayed type hypersensitivity type skin tests in patients with POF. Am J Reprod Immnulo 1995;33:495–502
   PubMed Web of Science ®Google Scholar
• Boumpass DT, Chrousos GP, Wilder RL, et al. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119:1198–208
   PubMed Web of Science ®Google Scholar
• Hill JA, Barbieri RL, Anderson DJ. Immunosuppressive effects of danazol in vitro. Fertil Steril 1987;48:414–8
   PubMed Web of Science ®Google Scholar
• Greenblatt RB, Dmowski WP, Mahesh VB, Scholer HF. Clinical studies with and antigonadotropin-Danazol. Fertil Steril 22:102–12
   PubMed Web of Science ®Google Scholar